Table 2.
The genotype distribution of HTTLPR between TN patients controls
| Genotype | TN | Control | Adjusted OR | 95% CI | Adjusted P | ||||
|---|---|---|---|---|---|---|---|---|---|
|
5-HTTLPR |
Long-long |
58 |
23.77% |
103 |
36.79% |
1.000 |
|
|
|
| |
Long-short |
99 |
40.57% |
129 |
46.07% |
1.363 |
0.900 |
2.064 |
0.143 |
| |
Short-short |
87 |
35.66% |
48 |
17.14% |
3.219 |
1.997 |
5.187 |
0.000 |
| |
Long |
215 |
44.06% |
335 |
59.82% |
1.000 |
|
|
|
| |
short |
273 |
55.94% |
225 |
40.18% |
1.891 |
1.478 |
2.418 |
0.045 |
| rs25531 |
AA |
68 |
27.87% |
75 |
26.79% |
1.000 |
|
|
|
| |
AG |
114 |
46.72% |
135 |
48.21% |
0.931 |
0.617 |
1.406 |
0.735 |
| |
GG |
62 |
25.41% |
70 |
25.00% |
0.977 |
0.608 |
1.569 |
0.923 |
| |
A |
250 |
51.23% |
285 |
50.89% |
1.000 |
|
|
|
| G | 238 | 48.77% | 275 | 49.11% | 0.987 | 0.774 | 1.258 | 0.913 | |